• Managing Director provides $2 million loan facility
• Directors defer payment of fees, salaries and incentives to 2027
• Actions highlight confidence in company's future prospects

Epsilon Healthcare Limited ('EPN' or the 'Company') has announced a series of measures to strengthen its working capital position and reinstate quotation on the Australian Securities Exchange ('ASX'). The key actions include:- Managing Director Peter Giannopoulos has provided a $2,000,000 irrevocable, unconditional and immediately enforceable loan facility to the Company through a promissory note. The loan amount is not contingent on any further conditions and will accrue interest at 15% per annum.- Between February 2025 and August 2025, Giannopoulos had personally contributed several interest-free loans to the Company totalling $275,000. The repayment date for this loan has now been extended to 30 June 2027.- Directors Alan Beasley and Zoe Hutchings are owed $190,000 and $60,000 respectively in director fees. The payment date for these fees has been extended to 31 March 2027.- Giannopoulos is owed an aggregate of $558,000 in salaries and short-term incentive payments. The payment date for these amounts has also been extended to 31 March 2027.The company states that these urgent actions taken by the directors and management highlight their confidence in EPN's future prospects.